JOHN NOSTA'S COLUMN

The Dangerous Myth of Digital Health Innovation: Build It And They Will Come

Products live on shelves and brands live in our minds--mindshare always precedes market share.

OK, I admit it. I’m a brand builder.  I’m cut from the mold of Proctor and Gamble and the single-minded proposition.  I don’t only like listening to peoples’ perceptions of a brand or movement—I like to shape them.  I like focus and defining that reality around an idea that “sticks to the roof of your customer’s brain”.  I like getting things down to a single concept or even a single word. Marketing is a bit of a science too and I believe it’s an important part of the technology revolution.  Unfortunately, it’s a part that gets funded after the science and technology—with a budget that is more defined by “what’s left over” than “what’s needed”.

When it comes to digital health, I see two critical realities.  The first is around the amazing opportunities in technology and health that will change the face of medicine.  The second is the marketing opportunity—no, marketing imperative to empower innovation with communication.  Yet my concern is that many innovators rely on the “power of the device” to drive adoption.  The strategy is simple—build it and they will come.  The problem starts with “it”.  Defining a digital health device beyond a sensor requires a solid understanding of the market.  And translating a core feature to a higher order benefit and/or value can be tricky. And this becomes even more complicated when parity devices fight for market share on based less on technology and more on brand position and personality. 

“A great product without great marketing is like winking at someone in the dark.  You known what you’re doing it, but no one else does!”

The other part of this simple statement is the “they”.  After you build it, just who is “they”?  The simple answer in digital health is often the patient—or consumer.  After all, it’s the era of patient empowerment where the individual stands up for their health and takes control.  Right?  Nope.  Many devices and newborn brands rely on this assumption and move to market with a single-minded strategy that doesn’t take into consideration the complicated buying process that engages both the rational and emotional decision-makers.  Simply put, the audience for digital health is a complex array of stakeholders—from the patient and caregiver to the physician and payor.  And one of the biggest challenges can be audience stratification and resource allocation. 

“To simple avoid the health care provider and expect the patient to drive adoption is risky.”

One thing is for sure.  Like a device itself, one size doesn’t fit all.  The role of the healthcare provider can be a critical path to driving adoption and long-term use.  Yet, in other instances, the validation by parents can be equally as powerful. The key is to leverage key influencers in a meaningful way.

Products live on shelves and brands live in our minds–mindshare always precedes market share.”

The power of innovation, medicine and the entire digital health movement is a function of the story we all craft. And that story can be as simple or complex as we want.  Certainly, the technology exists to manufacture many interesting and important devices. But these devices will always live on a shelf.  It’s the brands that will live in the minds of our customers.  Let’s make sure that we empower digital health with the resonant communication it deserves.

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

John Nosta
John Nostahttps://nostalab.com/
John is the founder of NostaLab, a digital health think tank recognized globally for an inspired vision of digital transformation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change and the diffusion of innovation into complex systems. He is also a member of the Google Health Advisory Board and the WHO’s Digital Health Roster of Experts. He is a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg as well as prestigious peer-reviewed journals including The American Journal of Physiology, Circulation, and The American Journal of Hematology.

JOHN NOSTA - INNOVATION THEORIST

John is the founder of NostaLab, a digital health think tank recognized globally for an inspired vision of digital transformation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change and the diffusion of innovation into complex systems.

He is also a member of the Google Health Advisory Board and the WHO’s Digital Health Roster of Experts. He is a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg as well as prestigious peer-reviewed journals including The American Journal of Physiology, Circulation, and The American Journal of Hematology.

Connect with John Nosta

Website

Twitter

LinkedIn

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.